Immunic grants 35M stock appreciation rights to employees and executives at $0.77 strike

IMMUNIC, INC.

Company authorized up to 35M SARs for employees and exec officers; 22,015,000 to exec officers.
Exercise price of $0.77 (July 7 closing); settlement in shares subject to shareholder approval to increase plan shares.
5M SARs exercisable Aug 1, 2026; 30M contingent on warrant exercises and private placement tranches from Jan 2024 offering.
Company intends to seek stockholder approval to amend 2019 Omnibus Equity Incentive Plan to increase authorized shares.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.